CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Raykov Rosty Director | Option exercise · Stock Options 10b5-1 | −15,598 | $2.45 | $38K | 1,618,586 |
| 2025-12-31 | Raykov Rosty Director | Grant or award 10b5-1 | +5,208 | 82,734 | ||
| 2025-12-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,382 | 176,916 | ||
| 2025-12-24 | Southpoint Capital Advisors LP 10% owner | Sale | −1,000,000 | $7.50 | $7.5M | 2,744,741 |
| 2025-12-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $7.54 | $75K | 77,526 |
| 2025-12-01 | Raykov Rosty Director | Grant or award | +5,208 | 87,526 | ||
| 2025-12-01 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,430 | 175,534 | ||
| 2025-11-18 | Southpoint Capital Advisors LP 10% owner | Sale | −19,341 | $8.79 | $170K | 3,744,741 |
| 2025-11-17 | Southpoint Capital Advisors LP 10% owner | Sale | −85,918 | $8.79 | $755K | 3,764,082 |
| 2025-11-14 | Southpoint Capital Advisors LP 10% owner | Sale | −160,100 | $8.00 | $1.3M | 3,850,000 |
| 2025-11-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $8.10 | $81K | 82,318 |
| 2025-10-31 | Raykov Rosty Director | Grant or award | +5,208 | 92,318 | ||
| 2025-10-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,430 | 173,104 | ||
| 2025-10-10 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +4,062 | $1.23 | $5K | 58,854 |
| 2025-10-10 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,775 | $9.24 | $16K | 57,079 |
| 2025-10-10 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −4,062 | $1.23 | $5K | 174,344 |
| 2025-10-09 | Southpoint Capital Advisors LP 10% owner | Sale | −20,609 | $9.35 | $193K | 4,010,100 |
| 2025-10-08 | Southpoint Capital Advisors LP 10% owner | Sale | −19,605 | $9.47 | $186K | 4,030,709 |
| 2025-10-08 | Raykov Rosty Director | Option exercise | +4,609 | $2.45 | $11K | 87,110 |
| 2025-10-08 | Raykov Rosty Director | Option exercise · Stock Options | −4,609 | $2.45 | $11K | 1,634,184 |
Page 7 of 8 · 159 trades